2 of 10

The Crisis in Knowledge Production

The Problem

We are drowning in data but starving for synthesis

Years

Average time from hypothesis to published finding

50%

Non-Reproducible

Biomedical research that cannot be replicated

Publication Overload

Millions of papers published annually with breakthroughs buried in latent knowledge

Bandwidth Limitations

No single researcher has the capacity for cross-domain synthesis

Synthesis Gap

Critical connections between fields remain undiscovered

3 of 10

The Market Opportunity

LLMs like GPT-4 are good at summarization — but summarization is not innovation. The true opportunity lies in synthesis of novel, testable, cross-domain hypotheses.

Monolithic Bias Problem

Centralized AI suffers from single-perspective limitations and training data constraints

Untapped Intersections

Prometheus mines the massive intersection of disparate literature to generate what humanity has not yet found

Novel Discovery Engine

Moving beyond summarization to true hypothesis generation and cross-domain innovation

4 of 10

Strategic Value Proposition

STRUCTURED HYPOTHESIS OBJECTS

Novelty Generation

Identifying unique causal chains absent from current literature or patent databases

Cross-Domain Synthesis

Breaking scientific silos — applying neuroscience signal processing to materials science

Falsifiable Intelligence

Actionable research paths with specific experimental protocols and clear failure criteria

5 of 10

Validator Design & Scoring Methodology

A comprehensive four-axis evaluation system ensures hypothesis quality and real-world applicability

Novelty

Real-time cross-referencing against PubMed, bioRxiv, patent databases

Mechanistic Coherence

Logical integrity of the proposed causal chain

Experimental Feasibility

Assessment of protocol and lab resource requirements

Predictive Accuracy

Long-term tracking against real-world experimental results

The Smoking Gun: Validators track hypotheses against actual experimental outcomes to ensure alignment with physical reality

6 of 10

The Hypothesis Object

STRUCTURED FORMAT

Miners submit comprehensive, structured outputs that ensure quality and reproducibility:

Hypothesis Statement

Clear, testable proposition with defined variables

Novelty Score

Quantified uniqueness (e.g., 0.94 — no direct literature overlap)

Causal Mechanism

Step-by-step explanation of the proposed pathway

Experimental Protocol

Detailed methodology (e.g., CRISPR-Cas9 knockout protocol)

Verified Citations

Supporting literature with DOIs for validation

Falsifiability Test

Clear criteria for hypothesis rejection

7 of 10

Retroactive Incentive Model

A revolutionary approach that aligns digital incentives with physical reality

Initial Rewards

Based on novelty and coherence scores

Lab Testing

Hypotheses tested in real-world experiments

Results Integration

Outcomes fed back asynchronously

Incentive Titration

Highest rewards for validated predictions

This model prevents convincing-sounding hallucinations by anchoring rewards to experimental outcomes, creating a self-correcting system that connects AI output to ground-truth.

8 of 10

Why Bittensor?

Structural Diversity

Specialized miners in Domain Clusters: Oncology, Materials Science, Climate Systems

Decentralized Scoring

No single corporate interest dictates valid hypotheses — governed by protocol and real-world results

Incentive Anchoring

Connects AI output to ground-truth through a self-correcting system

9 of 10

Competitive Landscape

PROMETHEUS ADVANTAGE

How Prometheus outperforms centralized AI and GPT wrappers across critical dimensions:

Dimension

Prometheus

Centralized AI

Reasoning Depth

Darwinian competition of diverse agents

Single-model summarization

Validation

Objective real-world scoring

Subjective internal benchmarks

IP Ownership

Transparent decentralized

Centralized opaque control

Innovation Type

Discontinuous cross-domain

Iterative training-data-based

10 of 10

Revenue Model & Go-To-Market

Tier 1: API Access & MVP

0–12 months

University labs & small biotechs: $500–$2,000/month
Enterprise pharma API subscriptions: $2,000–$20,000/month

Tier 2: Research Partnership

12–24 months

Co-development agreements
One validated drug target = $10M+ in royalties

Tier 3: Institutional Intelligence

24+ months

"The Bloomberg Terminal of Science"
Licensing to Big Pharma (Pfizer, Roche)
$8B+ annual R&D market opportunity

6-Month Execution Timeline

Months 1–2

Proof of Concept — 5–10 miners, Oncology focus, PubMed API integration

Months 3–4

"Smoking Gun" Demo — Retroactive validation showing 2024 discoveries from 2014 data

Months 5–6

First 10 Paying Customers via founders' domain network

Prometheus is a Bittensor subnet that runs a Darwinian tournament of AI scientific reasoning agents, competitively generating novel, falsifiable research hypotheses — scored by real experimental outcomes — and sells that intelligence to pharmaceutical and biotech companies as an R&D acceleration layer.

1 of 10